Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Alexander

Showing results (231-240 of 318) with videos related to

Pageof 32
Sort By:
Plos One|April 12, 2018
DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in miceJimmy Jianheng Zhou, Yuan Min Wang, Vincent W S Lee, et al.
Nephrology (Carlton, Vic.)|October 14, 2015
Development and function of Foxp3(+) regulatory T cellsYuan Min Wang, Joanna Ghali, Geoff Yu Zhang, et al.
Clinical and Experimental Immunology|February 3, 2017
Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out miceY M Wang, G Y Zhang, Y Wang, et al.
The American Journal of Pathology|July 11, 2009
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cellsGuoping Zheng, James Guy Lyons, Thian Kui Tan, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 2023
Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM diseaseTiti Chen, Qi Cao, Ruifeng Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activationRuifeng Wang, Titi Chen, Chengshi Wang, et al.
Kidney International|September 20, 2013
Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivoQi Cao, Yiping Wang, Dong Zheng, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2024
Foxp1 Is Required for Renal Intercalated Cell Differentiation and Acid-Base RegulationShi-Ting Wu, Yu Feng, Renhua Song, et al.
Kidney International|May 3, 2013
Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney diseaseJunyu Lu, Qi Cao, Dong Zheng, et al.
Nephrology (Carlton, Vic.)|August 4, 2015
Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney diseaseAllison Tong, David J Tunnicliffe, Pamela Lopez-Vargas, et al.
Pageof 32

Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Plos One|April 12, 2018
DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in miceJimmy Jianheng Zhou, Yuan Min Wang, Vincent W S Lee, et al.
Nephrology (Carlton, Vic.)|October 14, 2015
Development and function of Foxp3(+) regulatory T cellsYuan Min Wang, Joanna Ghali, Geoff Yu Zhang, et al.
Clinical and Experimental Immunology|February 3, 2017
Exacerbation of spontaneous autoimmune nephritis following regulatory T cell depletion in B cell lymphoma 2-interacting mediator knock-out miceY M Wang, G Y Zhang, Y Wang, et al.
The American Journal of Pathology|July 11, 2009
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cellsGuoping Zheng, James Guy Lyons, Thian Kui Tan, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 2023
Attenuation of renal injury by depleting cDC1 and by repurposing Flt3 inhibitor in anti-GBM diseaseTiti Chen, Qi Cao, Ruifeng Wang, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2018
Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activationRuifeng Wang, Titi Chen, Chengshi Wang, et al.
Kidney International|September 20, 2013
Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivoQi Cao, Yiping Wang, Dong Zheng, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2024
Foxp1 Is Required for Renal Intercalated Cell Differentiation and Acid-Base RegulationShi-Ting Wu, Yu Feng, Renhua Song, et al.
Kidney International|May 3, 2013
Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney diseaseJunyu Lu, Qi Cao, Dong Zheng, et al.
Nephrology (Carlton, Vic.)|August 4, 2015
Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney diseaseAllison Tong, David J Tunnicliffe, Pamela Lopez-Vargas, et al.
Pageof 32